Article Image
IPFS News Link • Science, Medicine and Technology

cancer diagnostics

• arclein

remarkably, the researchers noted that prostate cancer cells fluoresced under the microscope, while healthy, normal cells did not. Dr. Bishoff also notes that current tests have shown NV-VPAC1 to be extremely precise, with extremely low false positive rates. The next step is to conclude clinical trials and receive FDA approval. This is not a


ppmsilvercosmetics.com/ERNEST/